March 1, 2012

Vanderbilt HIV Vaccine Program seeks healthy, HIV-negative men and women for HIV vaccine study

In the United States HIV disproportionately infects certain groups and populations; however, HIV can infect anyone. Worldwide there are currently more than 40 million people infected with HIV. That number is growing.

Developing a vaccine is our best hope to control HIV/AIDS.
The Vanderbilt HIV Vaccine Program needs healthy, uninfected adults (ages 18-50) from all walks of life to help find a vaccine to prevent HIV infection.

There is no risk of HIV infection from the vaccines.
Volunteers must be available locally for 12-18 months. Volunteers will be compensated.

Call 322-HOPE (322-4673) or email for more information.

In order to develop a vaccine that will work for everyone, we need help from everyone. All racial and ethnic groups are encouraged to contact the program.